Clinical Scorecard: Determinants of Antibiotic Use and Bacterial Coinfection in Adults Diagnosed with Influenza

At a Glance

Key Highlights

• Influenza causes significant morbidity and mortality, with bacterial coinfection contributing to up to 25% of influenza-related deaths.
• RT-PCR allows for rapid diagnosis of influenza, but bacterial cultures take longer, complicating management.
• Antibiotic overprescription is common in viral RTIs, particularly in ED settings.
• Biomarkers may better predict bacterial coinfection than clinical signs alone.
• Strengthening antibiotic stewardship is essential to combat antimicrobial resistance.

Guideline-Based Recommendations

Diagnosis

• Utilize RT-PCR for accurate influenza diagnosis.
• Assess clinical signs and biomarkers to evaluate bacterial coinfection risk.

Management

• Implement antibiotic stewardship programs to reduce unnecessary antibiotic use.

Monitoring & Follow-up

• Monitor for signs of bacterial coinfection in patients diagnosed with influenza.

Risks

• Be aware of the risk of antibiotic overuse leading to antimicrobial resistance.

Patient & Prescribing Data

Adults with confirmed influenza presenting to the ED.

Antibiotics may be initiated despite confirmed influenza due to concerns about bacterial coinfection.

Clinical Best Practices

• Use clinical and biochemical factors to guide antibiotic initiation.
• Consider the duration of illness and comorbidities when assessing patients.

References

• Study on influenza morbidity and mortality
• RT-PCR testing for influenza
• Antibiotic stewardship importance